Christianlee wrote: ↑September 24th, 2022, 7:22 am New Bivalent shot in VAERs.
https://jessica5b3.substack.com/p/the-b ... dium=email
Snippet from the link:
There are 549 reports filed to VAERS as of September 17th, 2022 and of these, 74 (13.5%) are primary exposures (1st shots). This is astonishing as these new products were EUA ‘authorized’ only at the beginning of September: just 2 weeks passed until the first reports actually made it to the front-end of VAERS. Can you say, ‘safety signal’?
Of the 74 reports filed for first exposures, 10 (~13.5%) classified as severe, so far. Believe me, I am going to be keeping a close eye on this. But, to be clear, this really pisses me off. Most people who are being injected with this new ‘bivalent’ shot are doing so as a follow-up to previous shots! They are not only mixing products now but they are mixing types of injections! These things are NOT the same product as the previous ones (see saRNA article) and we, as data analysts, need the data to be remotely clean to determine whether or not the AEs being reported are due to the new products, or simply the by-product of damage already done by previous injections.